Roche buys rights to Evotec drugs

03/10/2009 | Bloomberg

Roche Holding has acquired the rights to a depression drug being developed by German biotech firm Evotec. Roche is also buying back from Evotec the rights to the EVT 100 family of drugs, which includes drugs for Alzheimer's disease and Parkinson's disease.

View Full Article in:

Bloomberg

Published in Brief:

SmartBrief Job Listings for Health Care

Job Title Company Location
Assistant General Counsel, Regulatory FDA
Cardinal Health
Columbus, OH
Assistant General Counsel
Cardinal Health
Columbus, OH
Regulatory Affairs Specialist
Stryker
Mahwah, NJ
Sr. Principal OptoMechanical Engineer - 14000008M2
Abbott
San Jose, CA
Senior Director Medical Affairs
Edwards Lifesciences
Irvine, CA